Tag Archives: TEVA

Top 10 Medical Stocks To Watch For 2018

US based but China focused small cap biopharmaceutical stockCASI Pharmaceuticals (NASDAQ: CASI) is up around 78% over the last three trading days on no apparent news on the newswires as the following chart illustrates:

CASI Pharmaceuticals is a U.S. based, late-stage small cap biopharmaceutical company focused on the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a focus on commercialization in China. The Company’s product pipeline features

EVOMELA庐, MARQIBO庐 and ZEVALIN庐, all U.S. Food and Drug Administration (FDA) approved drugs in-licensed from Spectrum Pharmaceuticals, Inc. for China regional rights, and currently in various stages in the regulatory and clinical process for market approval in China Proprietary drug candidate, ENMD-2076, ongoing in one Phase 2 clinical study CASI-001 and CASI-002, proprietary preclinical candidates in immune-oncology.

The Companyis headquartered in Rockville, Maryland and has a wholly owned subsidiary and R&D operations in Beijing, China.

Top 10 Medical Stocks To Watch For 2018: Guaranty Bancorp(GBNK)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PATRIOT FINANCIAL PARTNERS GP, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PATRIOT+FINANCIAL+PARTNERS+GP%2C+LP

    These are the top 5 holdings of PATRIOT FINANCIAL PARTNERS GP, LPBanc of California Inc (BANC) – 2,850,564 shares, 27.82% of the total portfolio. Guaranty Bancorp (GBNK) – 1,891,767 shares, 23.36% of the total portfolio. Shares reduced by 19.22%Meta Financial Group Inc (CASH) – 347,069 shares, 14.02% of the total portfolio. Sterling Bancorp (STL) – 1,048,980 shares, 11.07% of the total portfolio. Shares reduced by 16.01%MBT Financial Corp (MBTF) – 2,060,302 sha

Top 10 Medical Stocks To Watch For 2018: Popular, Inc.(BPOP)

Advisors’ Opinion:

  • [By Peter Graham]

    Founded in 1893, mid cap Popular Inc (NASDAQ: BPOP) is the leading banking institution by both assets and deposits in Puerto Rico and ranks among the top 50 U.S. banks by assets. Popular provides retail, mortgage and commercial banking services through its principal banking subsidiary, Banco Popular de Puerto Rico, as well as auto and equipment leasing and financing, investment banking, broker-dealer and insurance services through specialized subsidiaries. In the United States, Popular has established a community-banking franchise providing a broad range of financial services and products with branches in New York, New Jersey and Florida under the name of Popular Community Bank.

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Top 10 Medical Stocks To Watch For 2018: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Top 10 Medical Stocks To Watch For 2018: ClearSign Combustion Corporation(CLIR)

Advisors’ Opinion:

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

Top 10 Medical Stocks To Watch For 2018: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

Top 10 Medical Stocks To Watch For 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Paul Ausick]

    Teva Pharmaceuticals Industries Inc. (NYSE: TEVA) dropped about 25% Thursday to register a new 52-week low of $23.33 after closing at $31.25 on Wednesday. The 52-week high is $55.79. Volume was nearly 97 million, nearly 8 times the daily average. The company reported a second-quarter loss and slashed its outlook as competition is cutting into revenue.

  • [By Sean Williams]

    We’re in the thick of earnings season, which means some of the most prominent industry leaders are set to report their quarterly results. Tomorrow morning, Israel-based drug developer Teva Pharmaceutical Industries (NYSE:TEVA) is set to join the crowd and release its first-quarter financial results.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) posted a new 52-week low of $31.90 on Wednesday, down about 0.7% compared with Tuesday’s closing price of $32.14. The stock’s 52-week high is $58.16. Volume was about 65% below the daily average of around 9.7 million shares. The company had no specific news.

  • [By Keith Speights]

    Teva Pharmaceutical Industries (NYSE:TEVA) hasn’t had much good news lately. Shares of the Israel-based drugmaker were hit hard in the second half of 2016.

  • [By WWW.THESTREET.COM]

    However, the stock is recovering from a one-month loss of 5.82% after reports earlier this month that Soriot was being courted by Teva Pharmaceuticals (TEVA) .

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 3% Tuesday to post a new 52-week low of $15.45 after closing at $15.93 on Monday. The stock’s 52-week high is $52.66. Volume of around 13 million was about 15% below the daily average. The company had no specific news.

Top 10 Medical Stocks To Watch For 2018: Murphy Oil Corporation(MUR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

  • [By Ben Levisohn]

    Today, it was all about oil afterOPEC “reached an understanding” on capping oil production. And that made Murphy Oil (MUR) the hottest stock in the S&P 500.

  • [By Joshua Bondy]

    Murphy Oil (NYSE: MUR  ) has already spun off its US retail operations into Murphy Oil USAandis exploring the possibility of spinning off its U.K. refining operations. Divesting its refineries will help direct excess cash to developing new fields.

Top 10 Medical Stocks To Watch For 2018: TeleNav Inc.(TNAV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Telenav Inc (NASDAQ: TNAV) shares were also up, gaining 16 percent to $8.15 after the company reported the settlement of patent lawsuit. The company projects Q2 revenue of $51 million to $52 million and loss of $0.30 per share to $0.28 per share.

Top 10 Medical Stocks To Watch For 2018: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

Top 10 Medical Stocks To Watch For 2018: TAL International Group Inc.(TAL)

Advisors’ Opinion:

  • [By Craig Jones]

    Instead of buying TAL Education Group (ADR) (NYSE: TAL), Cramer would buy Alibaba Group Holding Ltd (NYSE: BABA).

    Cramer thinks Burlington Stores Inc (NYSE: BURL) is going to have a good quarter, because Ross Stores, Inc. (NASDAQ: ROST) posted a good one, and they have similar business models.

Mondays Vital Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corpor

U.S. stock futures are in rally mode this morning, with Dow Jones Industrial Average futures up more than 100 points in premarket trading. Tax plan optimism is the big driver heading into the week before the holiday break, as Republican’s now appear to have the votes to pass the much anticipated legislation.

stock market todaySpecifically, Treasury Secretary Steven Mnuchin said over the weekend that he has no doubt that the Republican tax plan will make it to the president’s desk this week, after Senators Bob Corker (R-Tenn.) and Marco Rubio (R-Fl.) ended their holdouts and said they’d support the bill.

Against this backdrop, Dow futures have soared 0.64%, S&P 500 futures have climbed 0.37% and Nasdaq-100 futures have jumped 0.37%.

On the options front, volume was over the top on Friday, with more than 24.2 million calls and 17.7 million puts changing hands on the session. Traders, it appears, are already preparing to go on break as the holiday season draws to a close. As for the CBOE, the single-session equity put/call volume ratio rose to 0.57, while the 10-day moving average ticked higher to 0.59.

Turning to Friday’s options activity, Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) was upgraded at Credit Suisse for announcing layoffs, but Israel’s largest labor union effectively shut the country down for half a day in protest. Elsewhere, Oracle Corporation (NASDAQ:ORCL) drew mixed options activity after a poorly received quarterly earnings report. Finally, Nvidia Corporation (NASDAQ:NVDA) rallied following a bullish note on GPU makers and cryptocurrencies.

Monday’s Vital Options Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corporation (NVDA)investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-300×138.png 300w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-65×30.png 65w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-200×92.png 200w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-400×183.png 400w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-116×53.png 116w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-100×46.png 100w,https://investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-109×50.png 109w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-78×36.png 78w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-170×78.png 170w” sizes=”(max-width: 552px) 100vw, 552px” />

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

TEVA stock surged more than 7% on on Friday after Credit Suisse upgraded the shares to “neutral” from “underperform” and lifted its price target to $20 from $8. The brokerage firm praised Israel-based Teva’s plan to layoff 10,000 employees as a positive turnaround move for investors.

However, the layoffs had the unintended consequence of practically shutting down Israel for half a day. The country’s biggest labor union went on strike for half of Sunday, closing the airport, stock exchange, banks and all government ministries in protest of the mass layoffs.

TEVA options traders clearly focused on the positives for the country. Volume topped 226,000 contracts, with activity rising to roughly 2.6 times TEVA’s daily average. Calls made up 60% of the day’s take. That said, January 2018 options activity reveals a bit of profit taking on TEVA.

Specifically, the January 2018 put/call open interest ratio rose last week from 0.55 on Monday to 0.64 as of this morning. Call volume remained heavy throughout the week, meaning that existing call positions were closed for a profit, or traders rolled their positions higher and into a later month to benefit from continued gains.

Oracle Corporation (ORCL)

Oracle released its quarterly earnings report last week, and the results were not well received at all. The company topped quarterly earnings and revenue expectations, but issued guidance below Wall Street’s targets. Specifically, Oracle said it expected revenue growth of 2%-4% with adjusted earnings of 68-70 cents per share, below the analyst estimate of 72 cents.

Furthermore, cloud growth, while solid for Oracle, remained well below that of competitors Microsoft Corporation (NASDAQ:MSFT) and Amazon.com, Inc. (NASDAQ:AMZN).

But ORCL stock is up this morning after announcing that the company was buying Australia’s Aconex Ltd for $1.19 billion. Aconex specializes in web-based project management software that could help boost Oracle’s presence in business cloud offerings.

ORCL options traders were mixed on last week’s earnings performance. Volume spiked to 186,000 contracts, or nearly five times Oracle’s daily average. That said, calls only made up 55% of the day’s take, as puts gained momentum on ORCL stock.

Furthermore, the January 2018 put/call OI ratio indicates a fair amount of pessimism, arriving at 0.91. Currently, peak put OI for the series totals 45,000 contracts at the out-of-the-money $40 strike.

Nvidia Corporation (NVDA)

NVDA stock has taken a bit of a beating in the past month, as analysts fret of the implosion of demand from cryptocurrency miners. However, RBC Capital Markets thinks the risks are being overstated. According to the ratings firm, while bitcoin and ethereum will both see less mining demand, every other cryptocurrency on the market is still going strong. As a result, Nvidia should continue to see strong demand for GPUs to mine these other currencies.

NVDA options traders gobbled up the bullish news. Volume jumped to 174,000 contracts on Friday, with calls making up 61% of the day’s take. What’s more, the attention to calls could mark a reversal in sentiment for NVDA.

Currently, the January 2018 put/call OI ratio arrives at a lofty 1.18 for NVDA stock. However, this reading has trended lower in recent weeks, as traders banked off a rebound in NVDA stock. Additional leverage from analyst notes on cryptocurrency miners could add fuel to this fire, and help push NVDA steadily higher heading into 2018.

As of this writing, Joseph Hargett did not hold a position in any of the aforementioned securities.

Compare Brokers

Top 10 Blue Chip Stocks For 2018

On Wednesday, stocks recovered following the worst day overall since October. The gains were led by the technology sector, which in many cases reversed following their worst day of the year on Tuesday.

However, despite the tech rebound, the blue chips lagged pulling the Dow Jones Industrial Average down less than 0.1%. Nike Inc (NYSE:NKE), a Dow component, fell 7.1%, pulled lower by a lackluster outlook for sales growth.

The technology sector of the S&P 500 rose 0.8%, its biggest gain in three weeks. The Nasdaq, which is tech heavy, rose 0.5%, and the 500 jumped chiefly on gains by technology giants Microsoft Corporation (NASDAQ:MSFT), up 1.3%, Apple Inc. (NASDAQ:AAPL), up 1.1%, and Facebook Inc (NASDAQ:FB), up 1.1%. The PHLX Semiconductor Index (NASDAQ:SOXX) did its part by gaining 1.1%.

Crude oil (WTI) fell 0.4% as data showed that stockpiles of crude hit a new record high. Spot WTI closed at $48.04 per barrel for a fall of 11% so far in March.

At the close, the Dow Jones Industrial Average fell 7 points at 20,661, the S&P 500 rose 4 to 2,348, the Nasdaq gained 28 points to close at 5,822, and the Russell 2000 fell a point to 1,346. The NYSE ‘s primary exchange traded 899 million shares with total volume of 3.5 billion shares, and the Nasdaq crossed 1.8 billion shares. On the Big Board, advancers exceeded decliners by 1.1-to-1, and on the Nasdaq, decliners led by 1.3-to-1. Blocks on the NYSE fell to 6,935 from 7,804 on Tuesday.

Top 10 Blue Chip Stocks For 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Chris Lange]

    Look for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) second-quarter results on Thursday. The consensus earnings estimate is $1.07 per share, on $5.73 billion in revenue. The shares were last seen at $32.34. The consensus price target is $36.91, and the 52-week trading range is $27.60 to $55.79.

  • [By Dan Caplinger]

    Momenta Pharmaceuticals soared 25% after the biotechnology company won a lawsuit over alleged patent infringement. A Delaware federal district court found that four patents held by Teva Pharmaceutical (NYSE:TEVA) were invalid, opening the door for Momenta to offer its own competing version of a key drug. Momenta CEO Craig Wheeler provided details in his praise of the decision, noting that it “further bolsters our confidence in the potential for us to offer multiple sclerosis patients a more affordable generic version of Copaxone 40 mg following regulatory approval.” Momenta still has to get past some additional hurdles, but investors are hopeful that the path forward is clearer.

  • [By WWW.MONEYSHOW.COM]

    Opioid drug abuse has become a national epidemic; Teva Pharmaceutical Industries Limited (TEVA) has just developed a drug that could potentially deliver pain relief without the scourge of addiction, suggests Jimmy Mengel, editor of The Crow’s Nest.

Top 10 Blue Chip Stocks For 2018: Tenneco Inc.(TEN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of auto-part makers like Delphi Automotive (DLPH), BorgWarner (BWA), and Tenneco (TEN) are getting killed today, ostensibly due to an article in Automotive News. Wells Fargo’s Richard Kwas and team think Tesla Motors (TSLA) and its Model 3 deserve at least some of the blame:

Top 10 Blue Chip Stocks For 2018: Brookfield Renewable Powerr Fund(BEP)

Advisors’ Opinion:

  • [By Federico Zaldua]

    I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let’s see whether you should go long on any of this separate -although related – entities.

    Good Operational Performance

    Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:

Top 10 Blue Chip Stocks For 2018: Amphenol Corporation(APH)

Advisors’ Opinion:

  • [By Darren Williams] Although the entire cannabis space has quietly taken a hit of their own medicine in recent weeks and gone to sleep, don’t think for one second the entire space isn’t going to light up again soon. That’s just what they do, right? However, knowing who the pretenders are and knowing who the contenders are is really the challenge when it’s comes right down to it.
    First, anyone who claims to be a grower or a seller of cannabis can’t for one second ever make it as a public company right now, or can even legally consider being a public company for that matter, so you can scratch any of those right off your list. At least here in the U.S. anyway, because Canada is already well ahead of the curve having legalized it for medicinal purposes already.
    More importantly, full legalization of marijuana in Canada appears to be on track for July 2018, which will make Canada just the second nation in the world after Uruguay to completely legalize the cultivation, sale and possession of the drug for medical and recreational purposes.
    Regardless, the best time to buy any stocks in a hot growth sector is when either everyone has forgotten about them, or when the overall market landscape has turned bearish, which has yet to happen. However, the former seems to be the case for the cannabis space, despite some very favorable state legislation last Fall.
    For now, as long as you have a license issued by Health Canada, you’re good to go, so there are some stocks trading in Canada already who are well on their way to making some green for investors. Canopy Growth Corporation (TSE: WEED), formerly Tweed Marijuana Inc., is a medical marijuana company based in Smiths Falls, Ontario. Aurora Cannabis Inc. (CVE: ACB), which is engaged in the production and sale of medical cannabis. There’s also Aphria Pharmaceutical Company (TSE: APH), which also is engaged in producing and selling medical marijuana through retail sales and wholesale channels.
    There are many more, but those are just a
  • [By Lee Jackson]

    This is the top pick in the sector and has remained a favorite at RBC for some time.Amphenol Corp. (NYSE: APH) is one of the worlds largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.

Top 10 Blue Chip Stocks For 2018: Yingli Green Energy Holding Company Limited(YGE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) is expected to post a quarterly loss at $1.48 per share on revenue of $372.30 million.

    Ameren Corp (NYSE: AEE) is estimated to post its quarterly earnings at $0.38 per share on revenue of $1.51 billion.

  • [By Spencer Israel]

    Axiom Capital Managing Director Gordon Johnson upgraded the entire alternative energy sector from Market Underweight to Market Overweight and upgraded SolarCity Corp (NASDAQ: SCTY) from Sell to Hold and Trina Solar Limited (ADR) (NYSE: TSL), Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Sell to Buy.

  • [By Wayne Duggan]

    Despite the potentially positive recent developments for solar investors, Johnson remains extremely bearish on solar stocks. Axiom maintains Sell ratings on the following U.S.-listed names:

    JA Solar Holdings Co. Ltd. (ADR) (NASDAQ: JASO) Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) Solaredge Technologies Inc (NASDAQ: SEDG) Canadian Solar Inc. (NASDAQ: CSIQ)

    Related Link: Politics Here And Abroad: Muted Market Volume Amid Comey’s Testimony And UK’s Election
    _______
    Image Credit: Screengrab from “Trump Makes Statement On Paris Accord” By The White House [Public domain], via Wikimedia Commons

Top 10 Blue Chip Stocks For 2018: iShares MSCI All Peru Capped ETF (EPU)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    ARGT, the lone exchange traded fund dedicated to Argentine equities, is up 19.6 percent year-to-date. That is good for the second-best showing among Latin America single-country ETFs, trailing only the iShares MSCI Capped Peru Index Fund (NYSE: EPU).

  • [By Andrew Efimoff] Related Some Positive Indexing News For A Frontier Markets ETF Why The Frontier Markets ETF Slumped Last Year Status Quo Decisions Would Bode Well For PAK ETF (Seeking Alpha)
    Related EPU Peru ETF Confronts Politics Commodities Call For The Colombia ETF Gra帽a Y Montero May Have Peaked In 2016 (Seeking Alpha) Gainers Pakistan: Global XMSCI Pakistan ETF (NYSE: PAK) is up 5.67 percent after receiving MSCI’s Emerging Markets Index approval. Peru: iShares MSCI All Peru Capped Index Fund(NYSE: EPU) is up 2.15 percent after Kuzynski won Peru’s nail-biting election. Philippines: iShares MSCI Philippines Investable(NYSE: EPHE) is up 2.21 percent after Macquarie Research said President Elect Rodrigo Duterte would lift the Pilipino property market. India: iShares MSCI India ETF (NYSE: INDA) is up 1.96 percent after India’s government relaxed regulation, making it easier for domestic airlines to fly overseas.

    Related Link: Some Positive Indexing News For A Frontier Markets ETF

Top 10 Blue Chip Stocks For 2018: Actinium Pharmaceuticals, Inc.(ATNM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Actinium Pharmaceuticals Inc (NYSE: ATNM) were down 24 percent to $1.29. Actinium priced 8 million shares at $1.25 per share.

    Shineco Inc (NASDAQ: TYHT) was down, falling around 32 percent to $19.50. On Wednesday, Shineco priced IPO at $4.50 per share.

Top 10 Blue Chip Stocks For 2018: PCM, Inc.(PCMI)

Advisors’ Opinion:

  • [By Lisa Levin]

    PCM Inc (NASDAQ: PCMI) was down, falling around 26 percent to $14.63. PCM reported Q2 adjusted earnings of $0.47 per share on sales of $560.1 million.

Top 10 Blue Chip Stocks For 2018: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

Top 10 Blue Chip Stocks For 2018: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Mondays Vital Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corpor

U.S. stock futures are in rally mode this morning, with Dow Jones Industrial Average futures up more than 100 points in premarket trading. Tax plan optimism is the big driver heading into the week before the holiday break, as Republican’s now appear to have the votes to pass the much anticipated legislation.

stock market todaySpecifically, Treasury Secretary Steven Mnuchin said over the weekend that he has no doubt that the Republican tax plan will make it to the president’s desk this week, after Senators Bob Corker (R-Tenn.) and Marco Rubio (R-Fl.) ended their holdouts and said they’d support the bill.

Against this backdrop, Dow futures have soared 0.64%, S&P 500 futures have climbed 0.37% and Nasdaq-100 futures have jumped 0.37%.

On the options front, volume was over the top on Friday, with more than 24.2 million calls and 17.7 million puts changing hands on the session. Traders, it appears, are already preparing to go on break as the holiday season draws to a close. As for the CBOE, the single-session equity put/call volume ratio rose to 0.57, while the 10-day moving average ticked higher to 0.59.

Turning to Friday’s options activity, Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) was upgraded at Credit Suisse for announcing layoffs, but Israel’s largest labor union effectively shut the country down for half a day in protest. Elsewhere, Oracle Corporation (NASDAQ:ORCL) drew mixed options activity after a poorly received quarterly earnings report. Finally, Nvidia Corporation (NASDAQ:NVDA) rallied following a bullish note on GPU makers and cryptocurrencies.

Monday’s Vital Options Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corporation (NVDA)investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-300×138.png 300w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-65×30.png 65w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-200×92.png 200w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-400×183.png 400w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-116×53.png 116w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-100×46.png 100w,https://investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-109×50.png 109w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-78×36.png 78w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-170×78.png 170w” sizes=”(max-width: 552px) 100vw, 552px” />

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

TEVA stock surged more than 7% on on Friday after Credit Suisse upgraded the shares to “neutral” from “underperform” and lifted its price target to $20 from $8. The brokerage firm praised Israel-based Teva’s plan to layoff 10,000 employees as a positive turnaround move for investors.

However, the layoffs had the unintended consequence of practically shutting down Israel for half a day. The country’s biggest labor union went on strike for half of Sunday, closing the airport, stock exchange, banks and all government ministries in protest of the mass layoffs.

TEVA options traders clearly focused on the positives for the country. Volume topped 226,000 contracts, with activity rising to roughly 2.6 times TEVA’s daily average. Calls made up 60% of the day’s take. That said, January 2018 options activity reveals a bit of profit taking on TEVA.

Specifically, the January 2018 put/call open interest ratio rose last week from 0.55 on Monday to 0.64 as of this morning. Call volume remained heavy throughout the week, meaning that existing call positions were closed for a profit, or traders rolled their positions higher and into a later month to benefit from continued gains.

Oracle Corporation (ORCL)

Oracle released its quarterly earnings report last week, and the results were not well received at all. The company topped quarterly earnings and revenue expectations, but issued guidance below Wall Street’s targets. Specifically, Oracle said it expected revenue growth of 2%-4% with adjusted earnings of 68-70 cents per share, below the analyst estimate of 72 cents.

Furthermore, cloud growth, while solid for Oracle, remained well below that of competitors Microsoft Corporation (NASDAQ:MSFT) and Amazon.com, Inc. (NASDAQ:AMZN).

But ORCL stock is up this morning after announcing that the company was buying Australia’s Aconex Ltd for $1.19 billion. Aconex specializes in web-based project management software that could help boost Oracle’s presence in business cloud offerings.

ORCL options traders were mixed on last week’s earnings performance. Volume spiked to 186,000 contracts, or nearly five times Oracle’s daily average. That said, calls only made up 55% of the day’s take, as puts gained momentum on ORCL stock.

Furthermore, the January 2018 put/call OI ratio indicates a fair amount of pessimism, arriving at 0.91. Currently, peak put OI for the series totals 45,000 contracts at the out-of-the-money $40 strike.

Nvidia Corporation (NVDA)

NVDA stock has taken a bit of a beating in the past month, as analysts fret of the implosion of demand from cryptocurrency miners. However, RBC Capital Markets thinks the risks are being overstated. According to the ratings firm, while bitcoin and ethereum will both see less mining demand, every other cryptocurrency on the market is still going strong. As a result, Nvidia should continue to see strong demand for GPUs to mine these other currencies.

NVDA options traders gobbled up the bullish news. Volume jumped to 174,000 contracts on Friday, with calls making up 61% of the day’s take. What’s more, the attention to calls could mark a reversal in sentiment for NVDA.

Currently, the January 2018 put/call OI ratio arrives at a lofty 1.18 for NVDA stock. However, this reading has trended lower in recent weeks, as traders banked off a rebound in NVDA stock. Additional leverage from analyst notes on cryptocurrency miners could add fuel to this fire, and help push NVDA steadily higher heading into 2018.

As of this writing, Joseph Hargett did not hold a position in any of the aforementioned securities.

Compare Brokers

Mondays Vital Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corpor

U.S. stock futures are in rally mode this morning, with Dow Jones Industrial Average futures up more than 100 points in premarket trading. Tax plan optimism is the big driver heading into the week before the holiday break, as Republican’s now appear to have the votes to pass the much anticipated legislation.

stock market todaySpecifically, Treasury Secretary Steven Mnuchin said over the weekend that he has no doubt that the Republican tax plan will make it to the president’s desk this week, after Senators Bob Corker (R-Tenn.) and Marco Rubio (R-Fl.) ended their holdouts and said they’d support the bill.

Against this backdrop, Dow futures have soared 0.64%, S&P 500 futures have climbed 0.37% and Nasdaq-100 futures have jumped 0.37%.

On the options front, volume was over the top on Friday, with more than 24.2 million calls and 17.7 million puts changing hands on the session. Traders, it appears, are already preparing to go on break as the holiday season draws to a close. As for the CBOE, the single-session equity put/call volume ratio rose to 0.57, while the 10-day moving average ticked higher to 0.59.

Turning to Friday’s options activity, Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) was upgraded at Credit Suisse for announcing layoffs, but Israel’s largest labor union effectively shut the country down for half a day in protest. Elsewhere, Oracle Corporation (NASDAQ:ORCL) drew mixed options activity after a poorly received quarterly earnings report. Finally, Nvidia Corporation (NASDAQ:NVDA) rallied following a bullish note on GPU makers and cryptocurrencies.

Monday’s Vital Options Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corporation (NVDA)investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-300×138.png 300w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-65×30.png 65w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-200×92.png 200w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-400×183.png 400w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-116×53.png 116w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-100×46.png 100w,https://investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-109×50.png 109w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-78×36.png 78w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-170×78.png 170w” sizes=”(max-width: 552px) 100vw, 552px” />

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

TEVA stock surged more than 7% on on Friday after Credit Suisse upgraded the shares to “neutral” from “underperform” and lifted its price target to $20 from $8. The brokerage firm praised Israel-based Teva’s plan to layoff 10,000 employees as a positive turnaround move for investors.

However, the layoffs had the unintended consequence of practically shutting down Israel for half a day. The country’s biggest labor union went on strike for half of Sunday, closing the airport, stock exchange, banks and all government ministries in protest of the mass layoffs.

TEVA options traders clearly focused on the positives for the country. Volume topped 226,000 contracts, with activity rising to roughly 2.6 times TEVA’s daily average. Calls made up 60% of the day’s take. That said, January 2018 options activity reveals a bit of profit taking on TEVA.

Specifically, the January 2018 put/call open interest ratio rose last week from 0.55 on Monday to 0.64 as of this morning. Call volume remained heavy throughout the week, meaning that existing call positions were closed for a profit, or traders rolled their positions higher and into a later month to benefit from continued gains.

Oracle Corporation (ORCL)

Oracle released its quarterly earnings report last week, and the results were not well received at all. The company topped quarterly earnings and revenue expectations, but issued guidance below Wall Street’s targets. Specifically, Oracle said it expected revenue growth of 2%-4% with adjusted earnings of 68-70 cents per share, below the analyst estimate of 72 cents.

Furthermore, cloud growth, while solid for Oracle, remained well below that of competitors Microsoft Corporation (NASDAQ:MSFT) and Amazon.com, Inc. (NASDAQ:AMZN).

But ORCL stock is up this morning after announcing that the company was buying Australia’s Aconex Ltd for $1.19 billion. Aconex specializes in web-based project management software that could help boost Oracle’s presence in business cloud offerings.

ORCL options traders were mixed on last week’s earnings performance. Volume spiked to 186,000 contracts, or nearly five times Oracle’s daily average. That said, calls only made up 55% of the day’s take, as puts gained momentum on ORCL stock.

Furthermore, the January 2018 put/call OI ratio indicates a fair amount of pessimism, arriving at 0.91. Currently, peak put OI for the series totals 45,000 contracts at the out-of-the-money $40 strike.

Nvidia Corporation (NVDA)

NVDA stock has taken a bit of a beating in the past month, as analysts fret of the implosion of demand from cryptocurrency miners. However, RBC Capital Markets thinks the risks are being overstated. According to the ratings firm, while bitcoin and ethereum will both see less mining demand, every other cryptocurrency on the market is still going strong. As a result, Nvidia should continue to see strong demand for GPUs to mine these other currencies.

NVDA options traders gobbled up the bullish news. Volume jumped to 174,000 contracts on Friday, with calls making up 61% of the day’s take. What’s more, the attention to calls could mark a reversal in sentiment for NVDA.

Currently, the January 2018 put/call OI ratio arrives at a lofty 1.18 for NVDA stock. However, this reading has trended lower in recent weeks, as traders banked off a rebound in NVDA stock. Additional leverage from analyst notes on cryptocurrency miners could add fuel to this fire, and help push NVDA steadily higher heading into 2018.

As of this writing, Joseph Hargett did not hold a position in any of the aforementioned securities.

Compare Brokers

Hot Undervalued Stocks To Invest In Right Now

The analysis provided in this article has found sufficient growth catalysts for BP’s (NYSE:BP) shares in the foreseeable future. The company’s business is shifting towards refining and petroleum products. In light of the global energy transition, we consider this as a factor of competitive advantage in the future. We also find that the company’ s shares can be considered attractive for income-seeking investors. Our DCF analysis shows that the stock is undervalued in the base scenario, which is built on an optimistic rate of revenue growth in the forecast period. The aggressive scenario sets an upside opportunity of up to 60% from the current market price of the stock.

We would like to start our analysis by examining the fundamentals and the last quarter’s report. First, the improved market conditions allowed company to increase revenue. You can see that the top line has achieved a level of $55B, up 45% on a year-over-year basis:

Hot Undervalued Stocks To Invest In Right Now: eBay Inc.(EBAY)

Advisors’ Opinion:

  • [By James E. Brumley]

    To say eBay Inc (NASDAQ:EBAY) is a big e-commerce outfit would be a significant understatement. It’s a giant, generating $8.9 billion worth of revenue for itself over the course of the past twelve months. That’s not the head-turner though. See, that’s just the cut eBay takes for itself, which is only a nominal percentage of the total amount of business in transacts. During the same twelve months, eBay facilitated sales of $83.3 billion worth of goods. Point being, while eBay is doing well, it’s sellers are doing even better. In some cases, eBay offers a game-changing opportunity for some companies to be in business.

    Up-and-coming star Namaste Technologies (OTCMKTS:NXTTF, CNSX:N) isn’t one of those companies that needs eBay on an existential basis, but now that it’s able to list its goods at the online auction site, don’t be surprised if NXTTF (or N, for investors in Canada) sees a skyrocketing top line.

    Namaste Technologies sells electronic vaporizers, which are more commonly categorized as electronic cigarettes (or e-cigs). Though initially intended as a means of avoiding tobacco smoke without giving up nicotine, it was only a matter of time before the idea was adapted and new technologies were developed to vaporize whatever it is people choose to smoke. Marijuana was an obvious good-fit candidate for the idea, and Namaste Technologies is simply capitalizing on that growing opportunity. The end result: Namaste now operates more than 30 e-commerce retail stores (with monthly traffic of over 550,000 visitors) in 20 countries targeting both medical and recreational users.

    Those who know the story of the advent of marijuana’s legalization and/or those who know eBay inside and out will know that eBay doesn’t allow listings of such paraphernalia… or at least didn’t. That changed in October, when eBay opened up its doors – selectively – while opening up a whole new product category called “Vape Pens, E-Cigarettes & Accessories.”

  • [By Stark Merrifield]

    That includes Yahoo! Inc. (Nasdaq: YHOO), Amazon.com Inc. (Nasdaq: AMZN), eBay Inc. (Nasdaq: EBAY), Alphabet Inc. (Nasdaq: GOOGL), and Facebook Inc. (Nasdaq: FB) – their combined market caps are worth $1.5 trillion.

  • [By Wayne Duggan]

    Taobao is the top mobile shopping app in China. The app is owned by Alibaba Group Holding Ltd (NYSE: BABA) and is most similar to eBay Inc (NASDAQ: EBAY).

  • [By WWW.THESTREET.COM]

    The only disappointing news for the day came from Verizon (VZ) , Travelers (TRV) and Ebay (EBAY) , Cramer said, but most investors didn’t even see that news amidst the flurry of positivity.

  • [By Ashley Moore]

    EBay Inc. (Nasdaq: EBAY) stock was volatile in 2016, but that volatility has ended. EBAY dropped 10% in October after announcing poor fiscal year 2016 earnings. Since then, eBay stock is up 19%, more than recovering from the initial losses.

  • [By Dustin Blitchok]

    The NBA authorized jersey sponsorships last year, and Flagstar joins companies such as Goodyear Tire & Rubber Co (NASDAQ: GT), Fitbit Inc (NYSE: FIT), eBay Inc (NASDAQ: EBAY) and General Electric Company (NYSE: GE) in sponsoring a team’s jersey.

Hot Undervalued Stocks To Invest In Right Now: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Chris Lange]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday. Previously, investors had responded positively to restructuring news, almost as if anything could pull this company out of the tailspin it has been in for this year.

  • [By WWW.MONEYSHOW.COM]

    Opioid drug abuse has become a national epidemic; Teva Pharmaceutical Industries Limited (TEVA) has just developed a drug that could potentially deliver pain relief without the scourge of addiction, suggests Jimmy Mengel, editor of The Crow’s Nest.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 3.6% Tuesday to post a new 52-week low of $15.32 after closing Friday at $15.90. The 52-week high is $52.66. Volume of around 18 million shares traded was about 10% above the daily average. The company had no specific news.

  • [By WWW.THESTREET.COM]

    Cramer and the AAP team are telling their investment club members to take a closer look at Allergan PLC (AGN) as it relates to the share price of Teva Pharmaceutical Industries Ltd. (TEVA) . Get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Keith Speights]

    Teva Pharmaceutical Industries (NYSE:TEVA) hasn’t had much good news lately. Shares of the Israel-based drugmaker were hit hard in the second half of 2016.

Hot Undervalued Stocks To Invest In Right Now: Cross Timbers Royalty Trust(CRT)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested shorting small cap trust stock Cross Timbers Royalty Trust (NYSE: CRT):

    On the close-up detailed chart of Cross Timber Royalty we can see how well-developed the downtrend is, but what’s so eye-catching is the way the selling volume is starting to build on the way down. The recent bearish crosses of all the key moving average lines were indeed telling of trouble.

Hot Undervalued Stocks To Invest In Right Now: The NeutriSci International (NU)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Matthew Briar]

    Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

Hot Undervalued Stocks To Invest In Right Now: ImmunoGen, Inc.(IMGN)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of ImmunoGen (NASDAQ:IMGN), a clinical-stage biotechnology company focused on finding cures for cancer with its proprietary antibody-drug conjugate platform, were rocketing higher by 29% as of 3 p.m. EST on Friday, apparently eager to ring in the new year with a bang.

  • [By Brian Orelli]

    ImmunoGen (NASDAQ:IMGN) is up 21.8% at 1:06 p.m. EST on no apparent news. Of course, it’s a biotech, so that’s often par for the course.

    So what

    One possibility is that day traders are just doing their thing, following the momentum, which pushes the stock price higher. We’ll know in a few days if the share price returns to previous levels.

  • [By Brian Orelli]

    ImmunoGen (NASDAQ:IMGN) is up 15.6% at 3:35 p.m. EDT on no news. The stock price bump might be a carryover from yesterday’s upgrade by Leerink Partners. Or maybe it’s short-sellers buying to cover their shorts after yesterday’s move. Or maybe it’s just because it’s a biotech and the sun came up today. Who knows?

Mondays Vital Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corpor

U.S. stock futures are in rally mode this morning, with Dow Jones Industrial Average futures up more than 100 points in premarket trading. Tax plan optimism is the big driver heading into the week before the holiday break, as Republican’s now appear to have the votes to pass the much anticipated legislation.

stock market todaySpecifically, Treasury Secretary Steven Mnuchin said over the weekend that he has no doubt that the Republican tax plan will make it to the president’s desk this week, after Senators Bob Corker (R-Tenn.) and Marco Rubio (R-Fl.) ended their holdouts and said they’d support the bill.

Against this backdrop, Dow futures have soared 0.64%, S&P 500 futures have climbed 0.37% and Nasdaq-100 futures have jumped 0.37%.

On the options front, volume was over the top on Friday, with more than 24.2 million calls and 17.7 million puts changing hands on the session. Traders, it appears, are already preparing to go on break as the holiday season draws to a close. As for the CBOE, the single-session equity put/call volume ratio rose to 0.57, while the 10-day moving average ticked higher to 0.59.

Turning to Friday’s options activity, Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) was upgraded at Credit Suisse for announcing layoffs, but Israel’s largest labor union effectively shut the country down for half a day in protest. Elsewhere, Oracle Corporation (NASDAQ:ORCL) drew mixed options activity after a poorly received quarterly earnings report. Finally, Nvidia Corporation (NASDAQ:NVDA) rallied following a bullish note on GPU makers and cryptocurrencies.

Monday’s Vital Options Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corporation (NVDA)investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-300×138.png 300w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-65×30.png 65w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-200×92.png 200w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-400×183.png 400w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-116×53.png 116w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-100×46.png 100w,https://investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-109×50.png 109w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-78×36.png 78w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-170×78.png 170w” sizes=”(max-width: 552px) 100vw, 552px” />

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

TEVA stock surged more than 7% on on Friday after Credit Suisse upgraded the shares to “neutral” from “underperform” and lifted its price target to $20 from $8. The brokerage firm praised Israel-based Teva’s plan to layoff 10,000 employees as a positive turnaround move for investors.

However, the layoffs had the unintended consequence of practically shutting down Israel for half a day. The country’s biggest labor union went on strike for half of Sunday, closing the airport, stock exchange, banks and all government ministries in protest of the mass layoffs.

TEVA options traders clearly focused on the positives for the country. Volume topped 226,000 contracts, with activity rising to roughly 2.6 times TEVA’s daily average. Calls made up 60% of the day’s take. That said, January 2018 options activity reveals a bit of profit taking on TEVA.

Specifically, the January 2018 put/call open interest ratio rose last week from 0.55 on Monday to 0.64 as of this morning. Call volume remained heavy throughout the week, meaning that existing call positions were closed for a profit, or traders rolled their positions higher and into a later month to benefit from continued gains.

Oracle Corporation (ORCL)

Oracle released its quarterly earnings report last week, and the results were not well received at all. The company topped quarterly earnings and revenue expectations, but issued guidance below Wall Street’s targets. Specifically, Oracle said it expected revenue growth of 2%-4% with adjusted earnings of 68-70 cents per share, below the analyst estimate of 72 cents.

Furthermore, cloud growth, while solid for Oracle, remained well below that of competitors Microsoft Corporation (NASDAQ:MSFT) and Amazon.com, Inc. (NASDAQ:AMZN).

But ORCL stock is up this morning after announcing that the company was buying Australia’s Aconex Ltd for $1.19 billion. Aconex specializes in web-based project management software that could help boost Oracle’s presence in business cloud offerings.

ORCL options traders were mixed on last week’s earnings performance. Volume spiked to 186,000 contracts, or nearly five times Oracle’s daily average. That said, calls only made up 55% of the day’s take, as puts gained momentum on ORCL stock.

Furthermore, the January 2018 put/call OI ratio indicates a fair amount of pessimism, arriving at 0.91. Currently, peak put OI for the series totals 45,000 contracts at the out-of-the-money $40 strike.

Nvidia Corporation (NVDA)

NVDA stock has taken a bit of a beating in the past month, as analysts fret of the implosion of demand from cryptocurrency miners. However, RBC Capital Markets thinks the risks are being overstated. According to the ratings firm, while bitcoin and ethereum will both see less mining demand, every other cryptocurrency on the market is still going strong. As a result, Nvidia should continue to see strong demand for GPUs to mine these other currencies.

NVDA options traders gobbled up the bullish news. Volume jumped to 174,000 contracts on Friday, with calls making up 61% of the day’s take. What’s more, the attention to calls could mark a reversal in sentiment for NVDA.

Currently, the January 2018 put/call OI ratio arrives at a lofty 1.18 for NVDA stock. However, this reading has trended lower in recent weeks, as traders banked off a rebound in NVDA stock. Additional leverage from analyst notes on cryptocurrency miners could add fuel to this fire, and help push NVDA steadily higher heading into 2018.

As of this writing, Joseph Hargett did not hold a position in any of the aforementioned securities.

Compare Brokers

Mondays Vital Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corpor

U.S. stock futures are in rally mode this morning, with Dow Jones Industrial Average futures up more than 100 points in premarket trading. Tax plan optimism is the big driver heading into the week before the holiday break, as Republican’s now appear to have the votes to pass the much anticipated legislation.

stock market todaySpecifically, Treasury Secretary Steven Mnuchin said over the weekend that he has no doubt that the Republican tax plan will make it to the president’s desk this week, after Senators Bob Corker (R-Tenn.) and Marco Rubio (R-Fl.) ended their holdouts and said they’d support the bill.

Against this backdrop, Dow futures have soared 0.64%, S&P 500 futures have climbed 0.37% and Nasdaq-100 futures have jumped 0.37%.

On the options front, volume was over the top on Friday, with more than 24.2 million calls and 17.7 million puts changing hands on the session. Traders, it appears, are already preparing to go on break as the holiday season draws to a close. As for the CBOE, the single-session equity put/call volume ratio rose to 0.57, while the 10-day moving average ticked higher to 0.59.

Turning to Friday’s options activity, Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) was upgraded at Credit Suisse for announcing layoffs, but Israel’s largest labor union effectively shut the country down for half a day in protest. Elsewhere, Oracle Corporation (NASDAQ:ORCL) drew mixed options activity after a poorly received quarterly earnings report. Finally, Nvidia Corporation (NASDAQ:NVDA) rallied following a bullish note on GPU makers and cryptocurrencies.

Monday’s Vital Options Data: Teva Pharmaceuticals, Inc. (TEVA), Oracle Corporation (ORCL) and Nvida Corporation (NVDA)investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-300×138.png 300w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-65×30.png 65w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-200×92.png 200w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-400×183.png 400w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-116×53.png 116w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-100×46.png 100w,https://investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-109×50.png 109w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-78×36.png 78w, investorplace.com/wp-content/uploads/2017/12/12-18-2017-Top-Ten-Options-170×78.png 170w” sizes=”(max-width: 552px) 100vw, 552px” />

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

TEVA stock surged more than 7% on on Friday after Credit Suisse upgraded the shares to “neutral” from “underperform” and lifted its price target to $20 from $8. The brokerage firm praised Israel-based Teva’s plan to layoff 10,000 employees as a positive turnaround move for investors.

However, the layoffs had the unintended consequence of practically shutting down Israel for half a day. The country’s biggest labor union went on strike for half of Sunday, closing the airport, stock exchange, banks and all government ministries in protest of the mass layoffs.

TEVA options traders clearly focused on the positives for the country. Volume topped 226,000 contracts, with activity rising to roughly 2.6 times TEVA’s daily average. Calls made up 60% of the day’s take. That said, January 2018 options activity reveals a bit of profit taking on TEVA.

Specifically, the January 2018 put/call open interest ratio rose last week from 0.55 on Monday to 0.64 as of this morning. Call volume remained heavy throughout the week, meaning that existing call positions were closed for a profit, or traders rolled their positions higher and into a later month to benefit from continued gains.

Oracle Corporation (ORCL)

Oracle released its quarterly earnings report last week, and the results were not well received at all. The company topped quarterly earnings and revenue expectations, but issued guidance below Wall Street’s targets. Specifically, Oracle said it expected revenue growth of 2%-4% with adjusted earnings of 68-70 cents per share, below the analyst estimate of 72 cents.

Furthermore, cloud growth, while solid for Oracle, remained well below that of competitors Microsoft Corporation (NASDAQ:MSFT) and Amazon.com, Inc. (NASDAQ:AMZN).

But ORCL stock is up this morning after announcing that the company was buying Australia’s Aconex Ltd for $1.19 billion. Aconex specializes in web-based project management software that could help boost Oracle’s presence in business cloud offerings.

ORCL options traders were mixed on last week’s earnings performance. Volume spiked to 186,000 contracts, or nearly five times Oracle’s daily average. That said, calls only made up 55% of the day’s take, as puts gained momentum on ORCL stock.

Furthermore, the January 2018 put/call OI ratio indicates a fair amount of pessimism, arriving at 0.91. Currently, peak put OI for the series totals 45,000 contracts at the out-of-the-money $40 strike.

Nvidia Corporation (NVDA)

NVDA stock has taken a bit of a beating in the past month, as analysts fret of the implosion of demand from cryptocurrency miners. However, RBC Capital Markets thinks the risks are being overstated. According to the ratings firm, while bitcoin and ethereum will both see less mining demand, every other cryptocurrency on the market is still going strong. As a result, Nvidia should continue to see strong demand for GPUs to mine these other currencies.

NVDA options traders gobbled up the bullish news. Volume jumped to 174,000 contracts on Friday, with calls making up 61% of the day’s take. What’s more, the attention to calls could mark a reversal in sentiment for NVDA.

Currently, the January 2018 put/call OI ratio arrives at a lofty 1.18 for NVDA stock. However, this reading has trended lower in recent weeks, as traders banked off a rebound in NVDA stock. Additional leverage from analyst notes on cryptocurrency miners could add fuel to this fire, and help push NVDA steadily higher heading into 2018.

As of this writing, Joseph Hargett did not hold a position in any of the aforementioned securities.

Compare Brokers

investment broker

Western Alliance (NYSE:WAL) is enjoying robust organic growth and executing a targeted acquisition strategy.

One arresting aspect of its growth since 2010 is that the company has grown revenues much faster than costs and now boasts great efficiency with a ~45% cost/income ratio. If Donald Trump’s election portends a newly torqued growth dynamic for U.S. domestic banks, WAL is the kind of name you want.

WAL is focused on a core footprint of Nevada, where it is headquartered, Arizona and Southern California. Recent quarters have seen its balance sheet continuing to grow at a 21% clip. Since 2010, about 80% of WAL’s growth has been organic and management expect this to continue.

Click to enlarge

investment broker: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Chris Lange]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).

  • [By Lisa Levin]

    Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.

investment broker: ABM Industries Incorporated(ABM)

Advisors’ Opinion:

  • [By Lisa Levin]

    ABM Industries, Inc. (NYSE: ABM) was down, falling around 16 percent to $36.98 after the company posted weak Q4 earnings and issued a downbeat full-year forecast.

investment broker: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    However, the stock is recovering from a one-month loss of 5.82% after reports earlier this month that Soriot was being courted by Teva Pharmaceuticals (TEVA) .

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 0.4% Thursday to post a 52-week low of $30.57 after closing at $30.70 Wednesday night. The stock’s 52-week high is $58.16. Volume was about half the daily average of nearly 9.3 million shares. The company launched it version of GSK’s asthma inhaler Advair today. Shares are on track to post a small gain after bouncing back from the early morning low.

  • [By Dan Caplinger]

    Momenta Pharmaceuticals soared 25% after the biotechnology company won a lawsuit over alleged patent infringement. A Delaware federal district court found that four patents held by Teva Pharmaceutical (NYSE:TEVA) were invalid, opening the door for Momenta to offer its own competing version of a key drug. Momenta CEO Craig Wheeler provided details in his praise of the decision, noting that it “further bolsters our confidence in the potential for us to offer multiple sclerosis patients a more affordable generic version of Copaxone 40 mg following regulatory approval.” Momenta still has to get past some additional hurdles, but investors are hopeful that the path forward is clearer.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 3% Tuesday to post a new 52-week low of $15.45 after closing at $15.93 on Monday. The stock’s 52-week high is $52.66. Volume of around 13 million was about 15% below the daily average. The company had no specific news.

  • [By Paul Ausick]

    Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA) dropped about 3.3% Tuesday to post a new 52-week low of $28.48 after closing at $29.44 on Monday. The stock’s 52-week high is $56.44. Volume of about 12.3 million was about 70% above the daily average of around 8 million shares traded. The company had no specific news.

investment broker: Brookline Bancorp Inc.(BRKL)

Advisors’ Opinion:

  • [By Dividends4Life]

    Memberships and Peers: PBCT is a member of the S&P 500 and a member of the Broad Dividend Achievers Index. The company’s peer group includes: Bank of America Corporation (BAC) with a 0.3% yield, Brookline Bancorp, Inc. (BRKL) with a 3.7% yield and Westfield Financial Inc. (WFD) with a 3.5% yield.

Top Growth Stocks To Own For 2018

Small cap Tex Mex or Mexican restaurant stock El Pollo LoCo Holdings Inc (NASDAQ: LOCO) reportedQ2 2017 earnings after the market closed Thursday.

Total revenue increased 8.3% to $105.6 million as system-wide comparable restaurant sales increased 2.9% -including a 2.4% increase for company-operated restaurants and a 3.2% increase for franchised restaurants. The growth in company-operated restaurant revenue was largely driven by the 24 new restaurants opened during and subsequent to the second quarter of 2016. Comparable company-operated restaurant sales increased 2.4%, driven by a 0.5% increase in transactions and a 1.9% increase in average check. Net income was $7.8 million versus net income of $7.3 million. The CEO commented:

“During the second quarter we achieved solid results, including system-wide comparable store sales growth of 2.9% and a return to positive transaction growth. Our core business continues to perform well, driven by our strategy to highlight our authentic brand, our differentiated offerings, and our QSR+ positioning. Additionally we made progress against new technology initiatives focused on driving convenience and loyalty, rolling out delivery and launching our all-new Loco Rewards loyalty program.”

Top Growth Stocks To Own For 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Sean Williams]

    We’re in the thick of earnings season, which means some of the most prominent industry leaders are set to report their quarterly results. Tomorrow morning, Israel-based drug developer Teva Pharmaceutical Industries (NYSE:TEVA) is set to join the crowd and release its first-quarter financial results.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 1.2% Wednesday to post a new 52-week low of $15.22 after closing Tuesday at $15.41. The 52-week high is $52.66. Volume of around 11 million shares traded was about 30% below the daily average. The company had no specific news.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 3.6% Tuesday to post a new 52-week low of $15.32 after closing Friday at $15.90. The 52-week high is $52.66. Volume of around 18 million shares traded was about 10% above the daily average. The company had no specific news.

  • [By Paul Ausick]

    Teva Pharmaceutical Industries Inc. (NYSE: TEVA) dropped about 4.6% Thursday to post a new 52-week low of $15.03 after closing at $44.64 on Wednesday. The 52-week high is $44.64. Volume was around 26 million, about 10% above the daily average. The company had no specific news.

Top Growth Stocks To Own For 2018: Oriental Financial Group Inc.(OFG)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap OFG Bancorp (NYSE: OFG) is a diversified financial holding company that operates under U.S. and Puerto Rico banking laws and regulations. Its three principal subsidiaries, Oriental Bank, Oriental Financial Services and Oriental Insurance, provide a full range of commercial, consumer and mortgage banking services, as well as financial planning, trust, insurance, investment brokerage and investment banking services, primarily in Puerto Rico, through 48 financial centers.

Top Growth Stocks To Own For 2018: Omega Protein Corporation(OME)

Advisors’ Opinion:

  • [By Lisa Levin]

    Omega Protein Corporation (NYSE: OME) was down, falling around 20 percent to $17.47 after the company reported weaker-than-expected results for its fourth quarter.

  • [By Lisa Levin]

    Omega Protein Corporation (NASDAQ: OME) shares dropped 21 percent to $20.65 after the company posted weak Q4 earnings.

    Shares of Endeavour Silver Corp (NYSE: EXK) were down around 22 percent to $3.41. Endeavour Silver reported a Q4 loss of $5.2 million.